Cytokinetics Inc
NASDAQ:CYTK

Watchlist Manager
Cytokinetics Inc Logo
Cytokinetics Inc
NASDAQ:CYTK
Watchlist
Price: 36.625 USD 6.93%
Market Cap: 4.4B USD
Have any thoughts about
Cytokinetics Inc?
Write Note

Intrinsic Value

CYTK's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CYTK stock under the Base Case scenario is 34.948 USD. Compared to the current market price of 36.625 USD, Cytokinetics Inc is Overvalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CYTK Intrinsic Value
34.948 USD
Overvaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare CYTK to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CYTK?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Cytokinetics Inc

Provide an overview of the primary business activities
of Cytokinetics Inc.

What unique competitive advantages
does Cytokinetics Inc hold over its rivals?

What risks and challenges
does Cytokinetics Inc face in the near future?

Has there been any significant insider trading activity
in Cytokinetics Inc recently?

Summarize the latest earnings call
of Cytokinetics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cytokinetics Inc.

Provide P/S
for Cytokinetics Inc.

Provide P/E
for Cytokinetics Inc.

Provide P/OCF
for Cytokinetics Inc.

Provide P/FCFE
for Cytokinetics Inc.

Provide P/B
for Cytokinetics Inc.

Provide EV/S
for Cytokinetics Inc.

Provide EV/GP
for Cytokinetics Inc.

Provide EV/EBITDA
for Cytokinetics Inc.

Provide EV/EBIT
for Cytokinetics Inc.

Provide EV/OCF
for Cytokinetics Inc.

Provide EV/FCFF
for Cytokinetics Inc.

Provide EV/IC
for Cytokinetics Inc.

Show me price targets
for Cytokinetics Inc made by professional analysts.

What are the Revenue projections
for Cytokinetics Inc?

How accurate were the past Revenue estimates
for Cytokinetics Inc?

What are the Net Income projections
for Cytokinetics Inc?

How accurate were the past Net Income estimates
for Cytokinetics Inc?

What are the EPS projections
for Cytokinetics Inc?

How accurate were the past EPS estimates
for Cytokinetics Inc?

What are the EBIT projections
for Cytokinetics Inc?

How accurate were the past EBIT estimates
for Cytokinetics Inc?

Compare the revenue forecasts
for Cytokinetics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cytokinetics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cytokinetics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cytokinetics Inc compared to its peers.

Compare the P/E ratios
of Cytokinetics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Cytokinetics Inc with its peers.

Analyze the financial leverage
of Cytokinetics Inc compared to its main competitors.

Show all profitability ratios
for Cytokinetics Inc.

Provide ROE
for Cytokinetics Inc.

Provide ROA
for Cytokinetics Inc.

Provide ROIC
for Cytokinetics Inc.

Provide ROCE
for Cytokinetics Inc.

Provide Gross Margin
for Cytokinetics Inc.

Provide Operating Margin
for Cytokinetics Inc.

Provide Net Margin
for Cytokinetics Inc.

Provide FCF Margin
for Cytokinetics Inc.

Show all solvency ratios
for Cytokinetics Inc.

Provide D/E Ratio
for Cytokinetics Inc.

Provide D/A Ratio
for Cytokinetics Inc.

Provide Interest Coverage Ratio
for Cytokinetics Inc.

Provide Altman Z-Score Ratio
for Cytokinetics Inc.

Provide Quick Ratio
for Cytokinetics Inc.

Provide Current Ratio
for Cytokinetics Inc.

Provide Cash Ratio
for Cytokinetics Inc.

What is the historical Revenue growth
over the last 5 years for Cytokinetics Inc?

What is the historical Net Income growth
over the last 5 years for Cytokinetics Inc?

What is the current Free Cash Flow
of Cytokinetics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cytokinetics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cytokinetics Inc

Current Assets 956.1m
Cash & Short-Term Investments 938.2m
Receivables 2m
Other Current Assets 15.8m
Non-Current Assets 308m
Long-Term Investments 150.7m
PP&E 144.6m
Other Non-Current Assets 12.7m
Current Liabilities 159.7m
Accounts Payable 13.9m
Accrued Liabilities 62.9m
Other Current Liabilities 82.9m
Non-Current Liabilities 1.4B
Long-Term Debt 645.2m
Other Non-Current Liabilities 725.6m
Efficiency

Free Cash Flow Analysis
Cytokinetics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cytokinetics Inc

Revenue
19.2m USD
Operating Expenses
-584.9m USD
Operating Income
-565.6m USD
Other Expenses
-49.6m USD
Net Income
-615.3m USD
Fundamental Scores

CYTK Profitability Score
Profitability Due Diligence

Cytokinetics Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional 3Y Average ROE
Exceptional ROIC
Exceptional ROE
66/100
Profitability
Score

Cytokinetics Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

CYTK Solvency Score
Solvency Due Diligence

Cytokinetics Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Negative Net Debt
Long-Term Solvency
43/100
Solvency
Score

Cytokinetics Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CYTK Price Targets Summary
Cytokinetics Inc

Wall Street analysts forecast CYTK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CYTK is 75.707 USD with a low forecast of 41.41 USD and a high forecast of 126 USD.

Lowest
Price Target
41.41 USD
13% Upside
Average
Price Target
75.707 USD
107% Upside
Highest
Price Target
126 USD
244% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cytokinetics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CYTK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CYTK Insider Trading
Buy and sell transactions by insiders

CYTK News

Other Videos
What is the Intrinsic Value of one CYTK stock?

The intrinsic value of one CYTK stock under the Base Case scenario is 34.948 USD.

Is CYTK stock undervalued or overvalued?

Compared to the current market price of 36.625 USD, Cytokinetics Inc is Overvalued by 5%.

Back to Top